CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program) Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR) Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study

EditorialFebruary 12, 2019 Vol 139, Issue 7

JOURNAL:Circulation. Article Link

Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns

Morrow DA, Wiviott SD. Keywords: cardivascular system; clinical study; trial design

FULL TEXT PDF